Literature DB >> 34144966

What is the optimal target for a T2T approach in axial spondyloarthritis?

Joachim Sieper1, Denis Poddubnyy2.   

Abstract

Entities:  

Keywords:  ankylosing; biological therapy; spondylitis; tumour necrosis factor inhibitors

Year:  2021        PMID： 34144966     DOI： 10.1136/annrheumdis-2021-220603

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Searching for New Genetic Biomarkers of Axial Spondyloarthritis.

Authors:  Bartosz Bugaj; Joanna Wielińska; Katarzyna Bogunia-Kubik; Jerzy Świerkot
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

2.  Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.

Authors:  Diego Benavent; Karen Franco-Gómez; Chamaida Plasencia-Rodriguez; Marta Novella-Navarro; Patricia Bogas; Romina Nieto; Irene Monjo; Laura Nuño; Alejandro Villalba; Diana Peiteado; Alejandro Balsa; Victoria Navarro-Compán
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.